Study of Risk Marker in CAD Patients

類似資料

• Risk Evaluation of Hepatocellular Carcinoma Using AFP as a Marker in Viral Hepatitis Patients
  著者:: Megha P.C
  出版事項: (2012)
• Comparative Study of HDL Cholesterol and APO-A1 in CAD Patients with or without Type 2 Diabetes
  著者:: Minusha C.
  出版事項: (2007)
• Serum Ferritin as a Risk Marker for Type2 Diabetic Coplications
  著者:: Surabhi C.
  出版事項: (2012)
• Comparative Study of Cardiac Markers such as Troponin T, CK-MB and CK in Myocardial Infarction Patients with and without Diabetes Mellitus
  著者:: Gopinath Pantharapadi
  出版事項: (2007)
• Organic Acids as Markers of Metabolic Disorders
  著者:: Nisha P.
  出版事項: (2007)